Cetrorelix acetate
NDC 67184-0605, Cetrorelix Acetate for Injection, kit, from Qilu Pharmaceutical Co., Ltd..
- Product NDC
- 67184-0605
- Status
- Listed
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- KIT
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217776
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0605 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67184-0605-2 | 67184060502 | 1 KIT in 1 CARTON (67184-0605-2) * 1 mL in 1 VIAL, GLASS (67184-0567-1) * 1 mL in 1 SYRINGE, GLASS (67184-0568-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c1f35ca4-3536-44ca-ad0e-02f484019456
Use it
Look up 67184-0605 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0605 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67184-0605. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.